Evaluation of methylene blue-mediated photodynamic inactivation in association with encapsulated nitric oxide donor in chitosan nanoparticles on Leishmania (L.) amazonensis. An in vitro study

Carregando...
Imagem de Miniatura

Data

Data de publicação

2018

Orientador

Título da Revista

ISSN da Revista

Título do Volume

É parte de

É parte de

É parte de

É parte de

LIGHT-BASED DIAGNOSIS AND TREATMENT OF INFECTIOUS DISEASES
Exportar
Mendeley

Projetos de Pesquisa

Unidades Organizacionais

Fascículo

Resumo
Cutaneous leishmaniasis (CL) is a chronic disease developed by parasites of the genus Leishmania that promotes destructive lesions. The available treatments are limited because of resistance and toxicity. Reactive oxygen species and nitric oxide (NO) are potentially toxic to these parasites. Photodynamic inactivation (PDI) has been explored as an alternative treatment once no reports about resistance have been described. Additionally, several studies indicate that the administration of exogenous NO donors represents an interesting strategy against CL. The aim of this work was to explore the effects of methylene blue (MB)-mediated PDI in association with encapsulated NO donors (S-nitroso-MSA) in chitosan nanoparticles (CSNPs) on Leishmania (L.) amazonensis. S-nitroso-MSA-CSNPs were tested with L. (L) amazonensis transgenic line expressing luciferase (La-LUC) at 25 μM, 50 μM, 75 μM, and 100 μM. PDI was perfomed using a red LED (λ= 66022 nm) at fluences of 12.5, 25, 37.5 and 50 J/cm² and MB at 100 μM. The association of both therapies was performed using 25 μM of S-nitroso-MSA-CSNP immediately after PDI at 25 J/cm² fluence. Results demonstrated a 50% decrease in La-LUC metabolic activity with 25 μM S-nitroso-MSA-CSNP and a 70% reduction with 25 J/cm² fluence when the tests were performed separately. However, the association with S-nitroso-MSA-CSNP showed 97% reduction of the parasite burden. The present study demonstrates that encapsulated S-nitroso-MSA-CSNPs were able to improve the effects of PDI on Leishmania (L.) amazonensis, which suggests that both therapies combined could be a potential alternative treatment for CL.

Como referenciar
CABRAL, FERNANDA V.; PELEGRINO, MILENA T.; DIMMER, JESICA A.; SEABRA, AMEDEA B.; RIBEIRO, MARTHA S. Evaluation of methylene blue-mediated photodynamic inactivation in association with encapsulated nitric oxide donor in chitosan nanoparticles on Leishmania (L.) amazonensis. An in vitro study. In: DAI, TIANHONG (ed.). In: LIGHT-BASED DIAGNOSIS AND TREATMENT OF INFECTIOUS DISEASES, January 27 - February 01, 2018, San Francisco, CA, USA. Abstract... Bellingham, WA, USA: Society of Photo-optical Instrumentation Engineers, 2018. (SPIE Proceedings Series, 10479). Disponível em: http://repositorio.ipen.br/handle/123456789/29501. Acesso em: 30 Dec 2025.
Esta referência é gerada automaticamente de acordo com as normas do estilo IPEN/SP (ABNT NBR 6023) e recomenda-se uma verificação final e ajustes caso necessário.

Agência de fomento